Navigation Links
BioPower Operations Corporation Announces that FTZ Exchange Signs Strategic Alliance with Capacity 360, LLC and Tom Settineri

FT. LAUDERDALE, Fla., Aug. 2, 2012 /PRNewswire/ -- BioPower Operations Corporation (OTCQB: BOPO) today announced that its wholly-owned subsidiary FTZ Exchange has executed a Strategic Alliance with Capacity 360, LLC and Founder Tom Settineri to develop excess capacity transactions.

Capacity 360, LLC is a company that assists Global 2000 corporations in developing excess capacity strategies to optimize and monetize their unused, under-utilized manufacturing capacities and assets, while meeting each corporation's strategic goals. Capacity 360's proven business model increases a corporate return on investment by utilizing excess capacity and realizing economies of scale combined with the development of new channels of distribution for the corporation's products, services and assets.

Thomas Settineri, the founder of Capacity 360, LLC, has over 30 years of experience in the establishment and implementation of proven Capacity and Marketing strategies as functional economic responses to a company's need for new business development for their internal and external markets. Mr. Settineri will be exclusive in providing the off-line management, expertise, and initial projects for the Strategic Alliance. The alliance is designed to develop trade disposition programs to unwind, remarket, and sell corporate capacities of unused, and under-utilized manufacturing time, products and services.

Mr. Settineri stated: "There are many benefits for major corporations, including increased credit and improvements in cash flow and working capital, wider market availability, increased sales and more jobs as a result of improved economic activity.  We are excited to bring our initial projects and opportunities to the strategic alliance. I have over 30 years of experience, along with my staff, in doing business with many multi-national corporations. We will offer FTZ a proven network of companies that will bring compelling opportunities and revenues to the Alliance."

Robert Kohn, BioPower Chairman and CEO, stated, "Mr. Settineri and I worked closely together when he was the President of a media purchasing and trading business doing $500 million in annual revenue.  Mr. Settineri's unique capacity business models are excellent methodologies for Global 2000 manufacturers to create jobs and increase profits."

The Alliances initial transactions will be developed off-line.  Our plans are to launch our FTZ Capacity Exchange. 

About BioPower Operations Corporation

FTZ Exchange LLC is a wholly-owned subsidiary of BioPower Operations Corporation and uses its business know-how of on-line and off-line commercial trade strategies to create transaction fee-based internet exchanges to sell products and services to business-to-business and business-to-consumer communities. FTZ currently owns 50% of the QX Health Exchange LLC, with Quture, Inc., a wholly owned subsidiary of Techs Loanstar, Inc. (OTCQB: TCLN).  QX Health Exchange intends to bring quality and competitively priced products and services to the global medical and healthcare marketplace.  The QX Health Exchange intends to establish a B2B and Health Provider to Patient (HP2P) Quality Health Exchange that will serve to connect hospitals/medical facilities; physicians; health workers; insurance providers, medical tourism and patients by providing quality health through valued products, services and technologies at competitive prices.  The QX Health Exchange also intends to sell its own branded health programs and products.

BioPower Operations Corporation is a development stage, reporting company, focused on growing biomass coupled with the production and sale of biomass products and byproducts. The senior management team has analyzed numerous biomass technologies and various market niche opportunities resulting in short term plans to produce and sell biomass oils that can be converted into oils, biofuels, animal feed or electricity.  Biomass is a broad term that encompasses all plant and animal matter that can be used either as a source of energy or for its chemical components when converted into bio oils, biofuels, green electricity, animal feed and other valuable products.

The company's websites can be viewed at and

Forward-Looking Safe Harbor Statement:

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act. The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Those statements include statements regarding the intent, belief or current expectations of BioPower Operations Corporation and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed.


Investor Relations 
Constellation Asset Advisors, Inc.

BioPower Operations Corporation

SOURCE BioPower Operations Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. BioPower Systems Awarded $5 Million from Victorian Government
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. inVentiv Health Selected to Provide Sales Operations Support for Santarus
4. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
5. StemCyte Adds World Class Talent to its North America and Global Operations
6. Vermillion Sharpens Focus and Streamlines Operations in 2012
7. Lend Lease Announces the Appointment of Tom Chapman as Director Operations for the Life Sciences Group in the Atlantic Region
8. Laureate Biopharma Appoints Les Mintzmyer, Vice President, Operations
9. Hospira Names John B. Elliot Senior Vice President of Operations
10. NanoLogix Provides Testing and Operations Update
11. Amarillo Biosciences Announces Plan to Open Asia Operations Center in Taipei, Taiwan
Post Your Comments:
(Date:10/8/2015)... SAN DIEGO , Oct. 8, 2015 /PRNewswire/ ... oncology company developing new treatments for cancer and ... Chief Executive Officer, will be presenting at the ... Las Vegas :Event:Aegis Capital Corporation 2015 ... PDTLocation:Brahms 2 room, The Encore @ The Wynn ...
(Date:10/8/2015)... , Oct. 8, 2015  ATCC, the premier ... that it has been selected by The Michael J. ... cell lines to academic, pharmaceutical, and biotechnology organizations committed ... the United States , and more ... the United States , and more ...
(Date:10/8/2015)... , Oct. 8, 2015 Celemics, a global ... into the North American market with the establishment of ... and Europe , has secured ... Target Enrichment methodology and sample preparation for DNA sequencing ... both hereditary and somatic genetic testing more accurately, quickly, ...
(Date:10/8/2015)... October 8, 2015 Global ... Global Biologics and Biosimilars industry . --> ... Biologics and Biosimilars Industry 2015 Deep Market Research ... is a professional and depth research report on ... ) , --> ...
Breaking Biology Technology:
... RICHMOND, Va., June 20 Insmed Inc. (Nasdaq:,INSM), ... that it intends to request a hearing before ... an earlier Staff Determination,to delist the Company,s common ... received a letter from The NASDAQ Stock Market ...
... Initiated to Find Suitable Candidate, WESLEY CHAPEL, ... today that Eran Rotem, its Chief,Financial Officer, who ... June 2008. The Company has initiated search for ... this position., Ram Ajjarapu commented: "We appreciate ...
... Germany – June 20, 2008 / b3c newswire ... contract manufacturing organization (CMO) for the development and ... of a 2,500 L multi-process production suite. Hence, ... with volumes of 30, 250, 500 and 2,500 ...
Cached Biology Technology:
(Date:9/30/2015)... Sept. 30, 2015  With nearly 300,000 Americans living ... new SCIs estimated to reach 12,500 annually, the role ... Resource Services for Independent Living (SCRS-IL) is increasingly ... California opening doors to independence for ... and services, notably assistive technology services and education. ...
(Date:9/29/2015)... SUNNYVALE, Calif. , Sept. 29, 2015 ... technology improves employee productivity while also saving energy ... features such as Low Power Active Mode and embedded ... workplace transformation Fujitsu today shows that ... of new and refreshed models to its enterprise desktop ...
(Date:9/28/2015)... Sept. 28, 2015  The monitoring of vital ... body temperature, is an essential component of patient ... of deterioration in a patient,s condition. However, in ... are typically taken during routine observation rounds only ... patient deteriorates between these observation rounds, the warning ...
Breaking Biology News(10 mins):
... Comparative Biology (SICB), one of the oldest and most ... at the Hilton San Francisco, Union Square, in San ... than 1,500 scientists will present the latest research on ... a rich assortment of news and feature possibilities. ...
... in biology are given the freedom to play, dabble in ... worry about getting "good" results? In the case ... level of new knowledge and publications generated by student-and-faculty teams. ... magazine, several scientists who have directed the Physiology course detail ...
... Chinese research team, led by Beijing Forestry University, BGI, Beijing ... has completed the first genomic sequence of Prunus mume ... the deeper understanding of Rosaceae evolution and provides an invaluable ... was published online today in Nature Communication ., As ...
Cached Biology News:
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications)....
Recognizes the VZV nucleocapsid by indirect immunofluorescence and immunoprecipitation. Shows cross-reactivity to HSV....
Mouse monoclonal [11C9] to Zeralenone ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to BSA: Zeralenone...
AK6 Antibody...
Biology Products: